Results 191 to 200 of about 112,050 (329)

Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease. [PDF]

Molecules, 2023
Manoharan A, Oh JM, Benny F, Kumar S, Abdelgawad MA, Ghoneim MM, Shaker ME, El-Sherbiny M, Almohaimeed HM, Gahtori P, Kim H, Mathew B.   +11 more
europepmc   +1 more source

IND-Enabling Preclinical Studies of [¹¹C]COU, a Trapped Metabolite PET Radiotracer for Monoamine Oxidase-B. [PDF]

Med Chem Res
Frazier M, Kaur T, Stauff J, Winton WP, Henderson BD, Dumond AS, Shao X, Raffel DM, Frey KA, Kilbourn MR, Brooks AF, Scott PJH.   +11 more
europepmc   +1 more source

Monoamine oxidase A from human placenta and monoamine oxidase B from bovine liver both have one FAD per subunit [PDF]

, 1989
Walter Weyler
openalex   +1 more source

Kinetic and quantitative analysis of [¹⁸F]SMBT-1 PET imaging for monoamine oxidase B. [PDF]

Ann Nucl Med
Hiraoka K, Mesfin B, Wu Y, Shimizu Y, Kikuchi A, Harada R, Ishiki A, Funaki Y, Furumoto S, Mugikura S, Okamura N, Kikuchi A, Yanai K, Arai H, Watabe H, Tashiro M.   +15 more
europepmc   +1 more source

Phenethylamine is a substrate of monoamine oxidase B in the paraventricular thalamic nucleus. [PDF]

Sci Rep, 2022
Obata Y, Kubota-Sakashita M, Kasahara T, Mizuno M, Nemoto T, Kato T.   +5 more
europepmc   +1 more source

Quantification of monoamine oxidase B expression with ¹¹C-SL25.1188 for imaging reactive astrocytes in patients with Alzheimer's disease. [PDF]

Eur J Nucl Med Mol Imaging
Matsuoka K, Takado Y, Kimura Y, Kitamura A, Kitamura H, Kanda M, Takada M, Ono M, Tatebe H, Endo H, Kurose S, Takahata K, Ikoma Y, Ichihashi M, Oya M, Hirata K, Matsumoto H, Orihara A, Kokubo N, Kataoka Y, Zhang H, Tagai K, Seki C, Shinotoh H, Kikuchi T, Ichise M, Shimizu H, Kakita A, Kawamura K, Zhang MR, Shimada H, Nagao K, Tokuda T, Higuchi M.   +33 more
europepmc   +1 more source

Oral KDS2010, a Monoamine Oxidase-B (MAO-B) Inhibitor, Slows the Deterioration of Motor Coordination in Genetic SCA1 Models by Inhibiting Astrocytic MAO-B-Mediated Inflammation. [PDF]

J Neurochem
Woo DH, Jeon JH, Ryu HJ, Lee GM, Lim HW, Park KD, Hoe KL, Rhee SD.   +7 more
europepmc   +1 more source

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside

, 2018
Marika Alborghetti, Ferdinando Nicoletti
openalex   +2 more sources

Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders

Brain : a journal of neurology, 2017
J. Tong, Gausiha Rathitharan, J. Meyer, Y. Furukawa, L. Ang, I. Boileau, M. Guttman, O. Hornykiewicz, S. Kish   +8 more
semanticscholar   +1 more source

New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer's Disease: A Review. [PDF]

ACS Omega
Chatzipieris FP, Kokkalis A, Georgiou N, Petsas E, Apostolou EV, Vougioukalakis GC, Mavromoustakos T.   +6 more
europepmc   +1 more source